Ovarian Cancer

PARP Inhibitor Slows Progression of Advanced Ovarian Cancer

Publish Date October 11, 2019

Veliparib added to chemotherapy, continued as maintenance tx prolongs progression-free survival.

PTSD Symptoms Tied to Higher Risk for Ovarian Cancer

Publish Date October 8, 2019

Correlation moderately attenuated after adjustment for health and ovarian cancer risk factors.

Geriatric Vulnerability Score Validated for Use in Managing Care of Older Patients With Ovarian Cancer

By

John Schieszer, MA

Publish Date September 29, 2019

Results of an analysis that validated the use of the GVS to determine vulnerability in older patients with ovarian cancer.

Oophorectomy More Effective Than Ultrasound Screening in Preventing BRCA1-Related Ovarian Cancer

By

Vicki Moore, PhD

Publish Date September 26, 2019

Results of a prospective study comparing effectiveness of ultrasound screening and salpingo-oophorectomy in preventing ovarian cancer are presented.

Germline BRCA2 Mutations Linked to Pediatric Lymphomas

By

Leah Lawrence

Publish Date September 3, 2019

Survivors of NHL should be offered genetic counseling.

Ovarian Cancer Clinical Trials

Clinical Trial: Specimen and Data Study for Ovarian Cancer Early Detection and Prevention

Clinical Trial: Prophylactic Salpingectomy With Delayed Oophorectomy

Clinical Trial: Interactive Educational Website for Women With Ovarian Cancer & Caregivers

Clinical Trial: Veliparib and Topotecan for Relapsed Ovarian Cancer With Negative or Unknown BRCA Status

Clinical Trial: AZD2281 Plus Carboplatin to Treat Breast and Ovarian Cancer